Bezuclastinib

DB18041InvestigationalSmall molecule

Bezuclastinib: Overview.

Chemical structure of Bezuclastinib
Formula / weight
C19H17N5O · 331.379 g/mol (avg)
Also known as
3,4-dimethyl-n-(2-phenyl-1h-pyrrolo(2,3-b)pyridin-5-yl)-1h-pyrazole-5-carboxamide · 3,4-dimethyl-N-(2-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazole-5- carboxamide
Code names
CGT9486 · PLX-9486

Resolves to

Compound
UNII2ROQ545LAGCAS1616385-51-3ChEMBLCHEMBL5095229
Structure
InChIKeyNVSHVYGIYPBTEZ-UHFFFAOYSA-NSMILESCC1=C(C)C(=NN1)C(=O)NC1=CN=C2NC(=CC2=C1)C1=CC=CC=C1
Targets
P10721KIT

What you can answer from here — as of October 01, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Bezuclastinib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In